Florsch B, Taugner J, Kasmann L, Kenndoff S, et al. Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy +/- immune checkpoint inhibition: a decade-long single-center historical analysis. J Cancer Res Clin Oncol 2023;149:3267-3276.
PMID: 35915184